A TOX-ic axis of epigenetic stem cell maintenance and chemoresistance in colon cancer

PLoS Biol. 2023 Sep 15;21(9):e3002295. doi: 10.1371/journal.pbio.3002295. eCollection 2023 Sep.

Abstract

Cancer stem cells drive tumor growth and survival via self-renewal and therapeutic resistance, but the upstream mechanisms are not well defined. In this issue of PLOS Biology, a study in colon cancer reveals a new signalling network that links epigenetic regulation to these phenotypes.

Publication types

  • Comment

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • Colonic Neoplasms* / drug therapy
  • Colonic Neoplasms* / genetics
  • Drug Resistance, Neoplasm* / genetics
  • Epigenesis, Genetic
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Neoplasm Proteins
  • Neoplastic Stem Cells
  • Phenotype

Substances

  • ABCG2 protein, human
  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • Neoplasm Proteins
  • WDR5 protein, human
  • Intracellular Signaling Peptides and Proteins

Grants and funding

The author(s) received no specific funding for this work.